Global Metabolic Disorder Therapeutics Market Size & Outlook
The global metabolic disorder therapeutics market size was estimated at USD 77,240.5 million in 2024 and is projected to reach USD 120,714.7 million by 2030, growing at a CAGR of 7.8% from 2025 to 2030.
Revenue, 2024 (US$M)
$77,240.5
Forecast, 2030 (US$M)
$120,714.7
CAGR, 2025 - 2030
7.8%
Report Coverage
Worldwide
Global metabolic disorder therapeutics market, 2018-2030 (US$M)
Related Markets
Global metabolic disorder therapeutics market highlights
- The global metabolic disorder therapeutics market generated a revenue of USD 77,240.5 million in 2024 and is expected to reach USD 120,714.7 million by 2030.
- The market is expected to grow at a CAGR (2025 - 2030) of 7.8% by 2030.
- In terms of segment, diabetes accounted for a revenue of USD 24,604.5 million in 2024.
- Lysosomal Storage Diseases is the most lucrative disease segment registering the fastest growth during the forecast period.
- In terms of region, North America was the largest revenue generating market in 2024.
- Country-wise, UK is expected to register the highest CAGR from 2025 to 2030.
Global data book summary
| Market revenue in 2024 | USD 77,240.5 million |
| Market revenue in 2030 | USD 120,714.7 million |
| Growth rate | 7.8% (CAGR from 2025 to 2030) |
| Largest segment | Diabetes |
| Fastest growing segment | Lysosomal Storage Diseases |
| Historical data covered | 2018 - 2023 |
| Base year for estimation | 2024 |
| Forecast period covered | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Lysosomal Storage Diseases, Diabetes, Obesity, Inherited Metabolic Disorders, Hypercholesterolemia, Other Metabolic Diseases |
Other key industry trends
- In terms of revenue, the North America accounted for 39.9% of the global metabolic disorder therapeutics market in 2024.
- By country, the U.S. is projected to lead the global market in terms of revenue in 2030.
- By country, UK is the fastest growing regional market and is projected to reach USD 8,121.5 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Metabolic Disorder Therapeutics Market Scope
Metabolic disorder therapeutics market segmentation & scope
Lysosomal Storage Diseases
Inherited Metabolic Disorders
Hypercholesterolemia
Diabetes
Obesity
Other Metabolic Diseases
Cellular Transplantation
Drug Therapy
Enzyme Replacement Therapy
Small Molecule Based Therapy
Substrate Reduction Therapy
Gene Therapy
Metabolic Disorder Therapeutics Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| BioMarin | View profile | - | - | - |
| Novo Nordisk A/S | View profile | - | - | - |
| Biocon | View profile | 10001+ | Bangalore, Karnataka, India, Asia | http://www.biocon.com |
| Takeda Pharmaceutical Co Ltd | View profile | 49095 | 1-1, Nihonbashi-Honcho 2-Chome, Chuo-ku, Tokyo, Japan, 103-8668 | https://www.takeda.com |
| AstraZeneca PLC | View profile | 89900 | 1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge, United Kingdom, CB2 0AA | https://www.astrazeneca.com |
| Eli Lilly and Co | View profile | 43000 | Lilly Corporate Center, Indianapolis, IN, United States, 46285 | https://www.lilly.com |
| Boehringer Ingelheim | View profile | 10001+ | Ingelheim Am Rhein, Rheinland-Pfalz, Germany, Europe | https://www.boehringer-ingelheim.com/ |
| Cipla Ltd DR | View profile | 38955 | Ganpatrao Kadam Marg, Cipla House, Peninsula Business Park, Lower Parel, Mumbai, MH, India, 400 013 | https://www.cipla.com |
| Bristol-Myers Squibb Co | View profile | 34100 | Route 206 and Province Line Road, Princeton, New Jersey, NJ, United States, 08543 | https://www.bms.com |
| Sanofi SA | View profile | 87994 | 46, avenue de la Grande Armée, Paris, France, 75017 | https://www.sanofi.com |
| AbbVie Inc | View profile | 50000 | 1 North Waukegan Road, North Chicago, IL, United States, 60064-6400 | http://www.abbvieinvestor.com |
| Merck KGaA | View profile | 62345 | Frankfurter Strasse 250, Darmstadt, HE, Germany, 64293 | https://www.emdgroup.com |
| Amgen Inc | View profile | 26700 | One Amgen Center Drive, Thousand Oaks, CA, United States, 91320-1799 | https://www.amgen.com |
| Johnson & Johnson | View profile | 134400 | One Johnson and Johnson Plaza, New Brunswick, NJ, United States, 08933 | https://www.jnj.com |
Global metabolic disorder therapeutics market size, by regions, 2018-2030 (US$M)
Top 10 countries: Metabolic disorder therapeutics market size, 2024 (US$M)
Global metabolic disorder therapeutics market share, by disease, 2024 & 2030 (%, US$M)
Metabolic disorder therapeutics market: Opportunity assessment by country
Global metabolic disorder therapeutics market, by region, 2024 (US$M)
Related statistics
No records
No related statistics found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
